Literature DB >> 6099831

Glycerokinase activity in human adipose tissue as related to obesity.

K Chakrabarty, J W Tauber, B Sigel, C T Bombeck, H Jeffay.   

Abstract

The activity of the enzyme glycerokinase is low in mammalian adipose tissue, but high in certain forms of genetic obesity in rats and mice. This study was undertaken to determine if obese human subjects had higher glycerokinase activity than normal-weight subjects. Seventy-three randomly selected patients undergoing abdominal surgery were studied. Subcutaneous and omental adipose tissue was removed during surgery and the activity of the enzyme glycerokinase was measured in vitro under optimal conditions. The following observations were made: (1) the mean activity, when expressed per microgram DNA, was significantly (P less than 0.05) higher in obese subjects at both sites, yet no direct correlation to the degree of obesity was found; (2) the individual activity in morbidly obese patients undergoing gastroplasty correlated inversely with the rate of postoperative weight loss (r = -0.58, P less than 0.05); (3) glycerokinase activity was directly related (r = 0.59, P less than 0.01) to the rate of spontaneous glycerol release, and inversely related (r = -0.51, P less than .025) to the stimulation in glycerol release by norepinephrine; (4) the ratio glycerokinase/lipoprotein lipase in omental adipose tissue correlated with the degree of obesity (r = 0.43, P less than 0.05); (5) in nondiabetic male obese adults, the glycerokinase activity in subcutaneous adipose tissue inversely correlated with age (P = 0.05) and (6) the glycerokinase activity had two apparent Km values in three obese patients, in which it was studied kinetically. It is concluded that a small subsection of the obese population have a high potential for glycerol phosphorylation. In these individuals, weight loss is more difficult since they tend to reutilize the glycerol formed by lipolysis and net glycerokinase activity in their adipose tissue may reflect variations in lipid turnover.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6099831

Source DB:  PubMed          Journal:  Int J Obes


  6 in total

1.  Uncoupling of 3T3-L1 gene expression from lipid accumulation during adipogenesis.

Authors:  Karla A Temple; Xheni Basko; Margaret B Allison; Matthew J Brady
Journal:  FEBS Lett       Date:  2007-01-16       Impact factor: 4.124

2.  Lipolytic signaling in response to acute exercise is altered in female mice following ovariectomy.

Authors:  Lindsay M Wohlers; Kathryn C Jackson; Espen E Spangenburg
Journal:  J Cell Biochem       Date:  2011-12       Impact factor: 4.429

3.  Glycerol as a correlate of impaired glucose tolerance: dissection of a complex system by use of a simple genetic trait.

Authors:  D Gaudet; S Arsenault; L Pérusse; M C Vohl; J St-Pierre; J Bergeron; J P Després; K Dewar; M J Daly; T Hudson; J D Rioux
Journal:  Am J Hum Genet       Date:  2000-03-27       Impact factor: 11.025

4.  A low-protein, high-carbohydrate diet increases fatty acid uptake and reduces norepinephrine-induced lipolysis in rat retroperitoneal white adipose tissue.

Authors:  Maísa P dos Santos; Suélem A de França; José Tiago F dos Santos; Samyra L Buzelle; Gisele L Bertolini; Maria Antonieta R Garófalo; Isis C do Kettelhut; Danúbia Frasson; Valéria E Chaves; Nair H Kawashita
Journal:  Lipids       Date:  2012-01-08       Impact factor: 1.880

5.  Glycerol is synthesized and secreted by adipocytes to dispose of excess glucose, via glycerogenesis and increased acyl-glycerol turnover.

Authors:  Floriana Rotondo; Ana Cecilia Ho-Palma; Xavier Remesar; José Antonio Fernández-López; María Del Mar Romero; Marià Alemany
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

6.  Resveratrol and Pterostilbene, Two Analogue Phenolic Compounds, Affect Aquaglyceroporin Expression in a Different Manner in Adipose Tissue.

Authors:  Saioa Gómez-Zorita; Jenifer Trepiana; Alfredo Fernández-Quintela; Marcela González; María P Portillo
Journal:  Int J Mol Sci       Date:  2018-09-07       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.